This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Management

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Seek expert advice

The management of the patient with haemophilia is based various principles:

  • correct the bleeding tendency
  • treat pain
  • prevent deformity
  • assist normal intellectual and emotional development in children with haemophilia
  • use of prophylaxis
    • primary goal of factor IX prophylaxis is to enhance the quality of life by reducing hemarthrosis episodes, preventing the progression into hemophilic arthropathy, and minimizing episodes of intracerebral and muscular bleeds (1)
    • choice of product should be individualized based on clinical factors and activity levels (2)

Reference:

  1. Alshaikhli A, Killeen RB, Rokkam VR. Hemophilia B. [Updated 2023 Oct 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560792/
  2. Konkle BA, Nakaya Fletcher S. Hemophilia B. 2000 Oct 2 [Updated 2024 Jun 6]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1495/

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.